Wockhardt Limited has informed the Exchange about press release dated 16-Mar-2022 titled National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt���s novel once-a-day MDR Gram-negative antibiotic WCK 6777
Wockhardt Limited has informed the Exchange about press release dated 16-Mar-2022 titled National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt���s novel once-a-day MDR Gram-negative antibiotic WCK 6777